Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.28 USD | +3.15% | +7.74% | +7.15% |
May. 08 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
May. 07 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.15% | 1.96B | |
-28.81% | 70.3B | |
+2.04% | 27.46B | |
-6.23% | 17.8B | |
+2.32% | 17.46B | |
+1.92% | 15.46B | |
+6.88% | 13.49B | |
+10.80% | 13.06B | |
+71.10% | 12.96B | |
+75.47% | 12.56B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Barclays Adjusts Price Target on Apollo Medical Holdings to $57 From $50, Reiterates Equalweight Rating